Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice
about
Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular CarcinomaMicroRNAs in Nonalcoholic Fatty Liver DiseaseEpigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutritionRole of regulatory micro RNAs in type 2 diabetes mellitus-related inflammationMicroRNAs as controlled systems and controllers in non-alcoholic fatty liver diseasePathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal CellsConsidering maternal dietary modulators for epigenetic regulation and programming of the fetal epigenomeEpithelial-mesenchymal transition: An emerging target in tissue fibrosisMicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma.MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice.The miRNAome of the postpartum dairy cow liver in negative energy balanceHypertrophy of ligamentum flavum in lumbar spine stenosis is associated with increased miR-155 level.Dicer1/miR-29/HMGCR axis contributes to hepatic free cholesterol accumulation in mouse non-alcoholic steatohepatitis.The roles of microRNA families in hepatic fibrosis.TRPV4 channel inhibits TGF-β1-induced proliferation of hepatic stellate cells.MicroRNA function in the profibrogenic interplay upon chronic liver disease.The role of miRNA-34a as a prognostic biomarker for cirrhotic patients with portal hypertension receiving TIPS.Pattern of microRNA expression associated with different stages of alcoholic liver disease in rat models.Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease.Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis.High-throughput sequencing of microRNAs in peripheral blood mononuclear cells: identification of potential weight loss biomarkers.Epigenetics: A New Bridge between Nutrition and Health.Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet.Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players.Relationship between differential hepatic microRNA expression and decreased hepatic cytochrome P450 3A activity in cirrhosisIntegrative genomics identifies candidate microRNAs for pathogenesis of experimental biliary atresia.The role of miRNAs in the regulation of inflammatory processes during hepatofibrogenesisRoles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cellsMicro RNAs in the development of non-alcoholic fatty liver disease.MicroRNA expression in the livers of inbred miceOverexpression of miR-155 in the liver of transgenic mice alters the expression profiling of hepatic genes associated with lipid metabolism.Possible role of tocopherols in the modulation of host microRNA with potential antiviral activity in patients with hepatitis B virus-related persistent infection: a systematic review.Potential epigenetic mechanism in non-alcoholic Fatty liver diseaseMicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis.MicroRNA Signature in Alcoholic Liver DiseaseHigh-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis.Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease.A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease.Role of MicroRNAs in Fibrosis.
P2860
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
P248
Q26767346-AD6DFD73-607D-4AED-8FCF-A9EE4D4267C4Q26774294-F8AB42C4-3EC5-4E3E-A95A-EBCD9E16B735Q26822513-F356A752-0BFE-46A7-BE89-C8F536596E10Q26830676-E02295E5-E62A-40C6-8895-8D9E3961123CQ26852606-918DD403-8CF7-4368-9779-B9BCE0A4A396Q28071596-531F1249-E622-4E32-995A-DEFD4DB903B8Q28080961-1ED5034E-9573-4776-9938-E241E15BC0C8Q28083351-67C13E3D-11AF-4565-BF96-88B455C6405FQ30439971-8F91860B-294D-4FFE-94B1-2CFAD52D9FB7Q31132757-8FB34387-28E3-4FE2-8281-E64D199610CBQ33622318-91056D27-89DD-463E-8C32-E9910486C297Q33736236-356F3DF3-3D9A-4A41-971A-7B4AC83B4BF3Q33759921-762E56F6-49E7-45C3-903B-4EB8432684A0Q33868794-7F9CB272-5B6C-4E33-9F68-5963A82857C8Q33889793-F0DFBB30-FCF9-490A-9278-B6CE81205F4FQ33907481-AB1B291A-9F6B-48B3-BEE7-BEA97FEDC890Q33961656-8DEC6E18-C550-432F-81DE-D1082F6A5224Q34000547-0B77344F-5BBC-4244-9DB4-449D7D9AD958Q34009053-F303A0DE-64E5-47D7-B32D-097C188676FFQ34169945-CFDD6149-86BD-4D07-9149-CC682BC9DFB3Q34555861-226E4F4C-8953-4507-A33B-AA93F998A18BQ34591910-12583E3A-959F-4281-B64D-5D70BE0C6F67Q34796362-A356B6DB-33FE-4887-AA09-E29B29430D75Q34821020-69A1FB8F-E019-4BDD-92A1-C3F12D05AFCDQ34994708-CBFC917E-E38D-4B71-AB98-B45E010D6F71Q35020627-630C80ED-1571-45D9-8032-C3FF414BBAB7Q35055339-0E90DBC0-D0DE-4803-9307-E49244D42767Q35080494-27C5249F-4E14-4A59-ADA8-4AB82F42EFB8Q35127045-0E9634D3-1E7E-4CFC-BA77-D32050F51C2BQ35195159-710A3886-1C59-44C8-8DED-1DAB326105AEQ35208224-85008975-F127-4151-9D50-081479F4F7B4Q35343911-E4BDEC78-D093-4C0D-8E43-5B35D2D845CEQ35380845-FCFAFD4F-3335-4D84-9839-058413B12FFDQ35652509-AF3D864C-E102-4318-BE53-8602F5D17444Q35810474-8E2A7559-62A2-4AD5-8969-04E0A08BFE27Q35958233-BD2882CA-0CF2-4969-AE5D-846FBCAD2C34Q35991723-3BBC1C21-B854-42B3-AEA6-9E97195F4A3AQ36005098-BA8A0AA8-0C3A-40C6-B9CB-064E6C29B16EQ36018329-54AD4A1B-151F-47C8-89A4-797A78139FC4Q36093326-DB8DC0AF-A627-4546-AC3C-D9CBD891DA3C
P2860
Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice
description
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2010
@ast
im Oktober 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2010/10/01)
@sk
vědecký článek publikovaný v roce 2010
@cs
wetenschappelijk artikel (gepubliceerd op 2010/10/01)
@nl
наукова стаття, опублікована в жовтні 2010
@uk
مقالة علمية (نشرت في أكتوبر 2010)
@ar
name
Difference in expression of he ...... oholic steatohepatitis in mice
@ast
Difference in expression of he ...... oholic steatohepatitis in mice
@en
Difference in expression of he ...... oholic steatohepatitis in mice
@nl
type
label
Difference in expression of he ...... oholic steatohepatitis in mice
@ast
Difference in expression of he ...... oholic steatohepatitis in mice
@en
Difference in expression of he ...... oholic steatohepatitis in mice
@nl
prefLabel
Difference in expression of he ...... oholic steatohepatitis in mice
@ast
Difference in expression of he ...... oholic steatohepatitis in mice
@en
Difference in expression of he ...... oholic steatohepatitis in mice
@nl
P2093
P2860
P50
P3181
P1476
Difference in expression of he ...... oholic steatohepatitis in mice
@en
P2093
Igor P Pogribny
Ivan Rusyn
Sharon A Ross
P2860
P2888
P304
P3181
P356
10.1038/LABINVEST.2010.113
P577
2010-06-14T00:00:00Z
P5875
P6179
1016608961